Gene-environment interactions in asthma and other respiratory diseases

Annual Review of Medicine

Volumn 56, Issue , 2005, Pages 383-400

  Kleeberger, Steven R ^a   Peden, David ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Allergen; Linkage analysis; Pollutant; Polymorphism

Indexed keywords

CD14 ANTIGEN; GLUTATHIONE TRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

ASTHMA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MULTIFACTORIAL INHERITANCE; OCCUPATIONAL LUNG DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ASTHMA; BRONCHITIS, CHRONIC; ENVIRONMENTAL POLLUTANTS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PNEUMOCONIOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; STATISTICS;

EID: 14544307941     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.56.062904.144908     Document Type: Review

References (109)

1. Sandford A, Weir T, Pare P. 1996. The genetics of asthma. Am. J. Respir. Crit. Care Med. 153:1749-65
2. Romieu I, Meneses F, Sienramonge JJL, et al. 1995. Effects of urban air pollutants on emergency room visits for childhood asthma in Mexico City. Am. J. Epidemiol. 141:546-53
3. Thurston GD, Lippmann M, Scott MB, et al. 1997. Summertime haze air pollution and children with asthma. Am. J. Respir. Crit. Care Med. 155:654-60
4. Timonen KL, Pekkanen J. 1997. Air pollution and respiratory health among children with asthmatic or cough symptoms. Am. J. Respir. Crit. Care Med. 156:546-52
5. Vedal S, Petkau J, White R, et al. 1998. Acute effects of ambient inhalable particles in asthmatic and nonasthmatic children. Am. J. Respir. Crit. Care Med. 157: 1034-43
6. Nafstad P, Øie L, Mehl R, et al. 1998. Residential dampness problems and development of bronchial obstruction in Norwegian children. Am. J. Respir. Crit. Care Med. 157:410-14
7. Rosenstreich DL, Eggleston P, Kattan M, et al. 1997. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N. Engl. J. Med. 336:1382-84
8. McConnell R, Berhane K, Gilliland F, et al. 2002. Asthma in exercising children exposed to ozone: a cohort study. Lancet 359:386-91
9. Khoury MJ, Adams MJ Jr, Flanders WD. 1988. An epidemiologic approach to ecogenetics. Am. J. Hum. Genet. 42:89-95
10. Khoury MJ, Beaty TH, Flanders WD. 1990. Epidemiologic approaches to the use of DNA markers in the search for disease susceptibility genes. Epidemiol. Rev. 12:41-55
11. Shields PG, Harris CC. 2000. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J. Clin. Oncol. 18:2309-15
12. Zhou W, Liu G, Miller DP, et al. 2002. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res. 62:1377-81
13. Silverman EK, Mosley JD, Palmer LJ, et al. 2002. Genome-wide linkage analysis of severe, early onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes. Hum. Mol. Genet. 11:623-32
14. Silverman EK, Palmer LJ, Mosley JD, et al. 2002. Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease. Am. J. Hum. Genet. 70:1229-39
15. Dowson LJ, Guest PJ, Stockley RA. 2001. Longitudinal changes in physiological, radiological, and health status measurements in α1-antitrypsin deficiency and factors associated with decline. Am. J. Respir. Crit. Care Med. 164:1805-9
16. Hirano K, Sakamoto T, Uchida Y, et al. 2001. Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Eur. Respir. J. 18:748-52
17. Ho L-I, Harn H-J, Chen C-J, et al. 2001. Polymorphism of the β2-adrenoceptor in COPD in Chinese subjects. Chest 120: 1493-99
18. Ishii T, Matsuse T, Teramoto S, et al. 2000. Association between alpha-1-antichymotrypsin polymorphism and susceptibility to chronic obstructive pulmonary disease. Eur. J. Clin. Invest. 30:543-48
19. Ishii T, Keicho N, Teramoto S, et al. 2001. Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis. Eur. Respir. J. 18:753-57
20. Kanazawa H, Okamoto T, Hirata K, et al. 2000. Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 162: 1235-38
21. Sakao S, Tatsumi K, Igari H, et al. 2001. Association of tumor necrosis factor α gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 163:420-22
22. Schurmann M, Reichel P, Muller-Myhsok B, et al. 2001. Results from a genome-wide search for predisposing genes in sarcoidosis. Am. J. Respir. Crit. Care Med. 164:840-46
23. Maliarik MJ, Chen KM, Sheffer RG, et al. 2000. The natural resistance-associated macrophage protein gene in African Americans with sarcoidosis. Am. J. Respir. Cell Mol. Biol. 22:672-75
24. Ober C, Moffatt MF. 2000. Contributing factors to the pathobiology. The genetics of asthma. Clin. Chest Med. 21:245-61
25. Sengler C, Lau S, Wahn U, et al. 2002. Interactions between genes and environmental factors in asthma and atopy: new developments. Respir. Res. 3:7-21
26. Busse WW, Lemanske RF Jr. 2001. Asthma. N. Engl. J. Med. 344:350-62
27. Peden DB. 2002. Influences on the development of allergy and asthma. Toxicology 181/182:323-28
28. Djukanovic R, Homeyard S, Gratziou C, et al. 1997. The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation. Am. J. Respir. Crit. Care Med. 155:826-32
29. Peden DB. 2003. Air pollution: indoor and outdoor. In Middleton's Allergy: Principles and Practice, ed. NF Adkinson Jr, JW Yunginger, WW Busse, et al., pp. 515-28. Philadelphia: Mosby
30. Rosenstreich DL, Eggleston P, Kattan M, et al. 1997. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N. Engl. J Med. 336: 1356-63
31. Platts-Mills TA. 1990. Allergens and asthma. Allergy Proc. 11:269-71
32. Martinez FD, Wright AL, Taussig LM, et al. 1995. Asthma and wheezing in the first six years of life. The Group Health. Medical Associates. N. Engl. J. Med. 332: 133-38
33. Postma DS, Gerritsen J, Holgate ST. 1999. The link between asthma and COPD. Foreword, summary and conclusions. Clin. Exp. Allergy 29(Suppl. 2):2-7
34. Chrysofakis G, Tzanakis N, Kyriakoy D, et al. 2004. Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest 125:71-76
35. Saetta M, Baraldo S, Turato G, et al. 2003. Increased proportion of CD8+ T-lymphocytes in the paratracheal lymph nodes of smokers with mild COPD. Sarcoidosis Vasc. Diffuse Lung Dis. 20:28-32
36. Barnes PJ. 2002. New treatments for COPD. Nat. Rev. Drug Discov. 1:437-46
37. Fagerstrom K. 2002. Smoking reduction in the management of COPD. Monaldi Arch. Chest Dis. 57:281-84
38. Mannino DM. 2002. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 121:121S-26S
39. Braun-Fahrlander C, Riedler J, Herz U, et al. 2002. Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med. 347: 869-77
40. Liu AH. 2002. Endotoxin exposure in allergy and asthma: reconciling a paradox. J. Allergy Clin. Immunol. 109:379-92
41. Gereda JE, Klinnert MD, Price MR, et al. AH. 2001. Metropolitan home living conditions associated with indoor endotoxin levels. J. Allergy Clin. Immunol. 107:790-96
42. Gereda JE, Leung DY, Thatayatikom A, et al. 2000. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 355:1680-83
43. Gold DR. 2000. Environmental tobacco smoke, indoor allergens, and childhood asthma. Environ. Health Perspect. 108(Suppl. 4):643-51
44. Ziegler-Heitbrock HW, Ulevitch RJ. 1993. CD14: cell surface receptor and differentiation marker. Immunol. Today 14:121-25
45. Alexis N, Eldridge M, Reed W, et al. 2001. CD14-dependent airway neutrophil response to inhaled LPS: role of atopy. J. Allergy Clin. Immunol. 107:31-35
46. Vercelli D. 2002. The functional genomics of CD14 and its role in IgE responses: an integrated view. J. Allergy Clin. Immunol. 109:14-21
47. Koppelman GH, Reijmerink NE, Colin SO, et al. 2001. Association of a promoter polymorphism of the CD14 gene and atopy. Am. J. Respir. Crit. Care Med. 163:965-69
48. O'Donnell AR, Toelle BG, Marks GB, et al. 2004. Age-specific relationship between CD14 and atopy in a cohort assessed from age 8 to 25 years. Am. J. Respir. Crit. Care Med. 169:615-22
49. Park JH, Gold DR, Spiegelman DL, et al. 2001. House dust endotoxin and wheeze in the first year of life. Am. J. Respir. Crit. Care Med. 163:322-28
50. Woo JG, Assa'ad A, Heizer AB, et al. 2003. The -159 C→T polymorphism of CD14 is associated with nonatopic asthma and food allergy. J. Allergy Clin. Immunol. 112:438-44
51. Gilliland FD, Berhane K, Li YF, Rappaport EB, et al. 2003. Effects of early onset asthma and in utero exposure to maternal smoking on childhood lung function. Am. J. Respir. Crit. Care Med. 167:917-24
52. Gilliland FD, Li YF, Peters JM. 2001. Effects of maternal smoking during pregnancy and environmental tobacco smoke on asthma and wheezing in children. Am. J. Respir. Crit. Care Med. 163:429-36
53. Salam MT, Li YF, Langholz B, Gilliland FD. 2004. Early-life environmental risk factors for asthma: findings from the children's health study. Environ. Health Perspect. 112:760-65
54. Rumold R, Jyrala M, Diaz-Sanchez D. 2001. Secondhand smoke induces allergic sensitization in mice. J. Immunol. 167: 4765-70
55. Bastain TM, Gilliland FD, Li YF, et al. 2003. Intraindividual reproducibility of nasal allergic responses to diesel exhaust particles indicates a susceptible phenotype. Clin. Immunol. 109:130-36
56. Diaz-Sanchez D, Garcia MP, Wang M, et al. 1999. Nasal challenge with diesel exhaust particles can induce sensitization to a neoallergen in the human mucosa. J. Allergy Clin. Immunol. 104:1183-88
57. Finkelman FD, Yang M, Orekhova T, et al. 2004. Diesel exhaust particles suppress in vivo IFN-gamma production by inhibiting cytokine effects on NK and NKT cells. J. Immunol. 172:3808-13
58. Gilliland FD, Li YF, Saxon A, et al. 2004. Effect of glutathione-S- transferase M1 and P1 genotypes on xenobiotic enhancement of allergic responses: randomised, placebo-controlled crossover study. Lancet 363:119-25
59. Gilliland FD, Gauderman WJ, Vora H, et al. 2002. Effects of glutathione-S-transferase M1, T1, and P1 on childhood lung function growth. Am. J. Respir. Crit. Care Med. 166:710-16
60. Gilliland FD, Li YF, Dubeau L, et al. 2002. Effects of glutathione S-transferase M1, maternal smoking during pregnancy, and environmental tobacco smoke on asthma and wheezing in children. Am. J. Respir. Crit Care Med. 166:457-63
61. Gilliland FD, Rappaport EB, Berhane K, et al. 2002. Effects of glutathione S-transferase P1, M1, and T1 on acute respiratory illness in school children. Am. J. Respir. Crit. Care Med. 166:346-51
62. David GL, Romieu I, Sienra-Monge JJ, et al. 2003. Nicotinamide adenine dinucleotide (phosphate) reduced:quinone oxidoreductase and glutathione S-transferase M1 polymorphisms and childhood asthma. Am. J. Respir. Crit. Care Med. 168:1199-204
63. Romieu I, Sienra-Monge JJ, Ramirez-Aguilar M, et al. 2004. Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City. Thorax 59:8-10
64. Mira JP, Cariou A, Grall F, et al. 1999. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA 282:561-68
65. Tang GJ, Huang SL, Yien HW, et al. 2000. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit. Care Med. 28:2733-36
66. Albuquerque RV, Hayden CM, Palmer LJ, et al. 1998. Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma. Clin. Exp. Allergy 28:578-84
67. Huang SL, Su CH, Chang SC. 1997. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am. J. Respir. Crit. Care Med. 156:1436-39
68. Sandford AJ, Chagani T, Weir TD, et al. 2001. Susceptibility genes for rapid decline of lung function in the lung health study. Am. J. Respir. Crit. Care Med. 163:469-73
69. Sakao S, Tatsumi K, Igari H, et al. 2001. Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 163:420-22
70. Teramoto S, Ishii T. 2001. No association of tumor necrosis factor-alpha gene polymorphism and COPD in Caucasian smokers and Japanese smokers. Chest 119:315-16
71. Di Somma C, Charron D, Deichmann K, et al. 2003. Atopic asthma and TNF-308 alleles: linkage disequilibrium and association analyses. Hum. Immunol. 64: 359-65
72. Zhu S, Chan-Yeung M, Becker AB, et al. 2000. Polymorphisms of the IL-4, TNF-α, and FcαRIβ genes and the risk of allergic disorders in at-risk infants. Am. J. Respir. Crit. Care Med. 161:1655-59
73. Hull J, Thomson AH. 1998. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax 53:1018-21
74. Maier LA, Raynolds MV, Young DA, et al. 1999. Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease. Am. J. Respir. Crit. Care Med. 159:1342-50
75. Richeldi L, Sorrentino R, Saltini C. 1993. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 262:242-44
76. Nadif R, Jedlicka A, Mintz M, et al. 2003. Role of TNF and LTA polymorphisms on biological markers of response to oxidative stimuli in coal miners: a model of gene-environment interaction. J. Med. Genet. 40:96-103
77. Zhai R, Jetten M, Schins RP, et al. 1998. Polymorphisms in the promoter of the tumor necrosis factor-alpha gene in coal miners. Am. J. Ind. Med. 34:318-24
78. Corbett EL, Mozzato-Chamay N, Butterworth AE, et al. 2002. Polymorphisms in the tumor necrosis factor-alpha gene promoter may predispose to severe silicosis in black South African miners. Am. J. Respir. Crit. Care Med. 165:690-93
79. Mozzato-Chamay N, Corbett EL, Bailey RL, et al. 2001. Polymorphisms in the IkB-a promoter region and risk of diseases involving inflammation and fibrosis. Genes Immun. 2:153-55
80. Ueki A, Isozaki Y, Tomokuni A, et al. 2001. Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain. Immunobiology 204:458-65
81. Yucesoy B, Vallyathan V, Landsittel DP, et al. 2001. Association of tumor necrosis factor-alpha and interleukin-1 gene polymorphisms with silicosis. Toxicol. Appl. Pharmacol. 172:75-82
82. Mapp CE, Balboni A, Baricordi R, et al. 1997. Human leukocyte antigen associations in occupational asthma induced by isocyanates. Am. J. Respir. Crit. Care Med. 156:S139-43
83. Piirila P, Wikman H, Luukkonen R, et al. 2001. Glutathione S-transferase genotypes and allergic responses to diisocyanate exposure. Pharmacogenetics 11:437-45
84. Home C, Quintana PJE, Keown PA, et al. 2000. Distribution of DRB1 and DQB1 HLA class II alleles in occupational asthma due to western red cedar. Eur. Respir. J. 15:911-14
85. Lombardi G, Germain C, Uren J, et al. 2001. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. J. Immunol. 166:3549-55
86. McCanlies EC, Kreiss K, Andrew M, et al. 2003. HLA-DPB1 and chronic beryllium disease: a HuGE review. Am. J. Epidemiol. 157:388-98
87. Jagirdar J, Begin R, Dufresne A, et al. 1996. Transforming growth factor-beta (TGF-beta) in silicosis. Am. J. Respir. Crit. Care Med. 154:1076-81
88. Borm PJ, Schins RP. 2001. Genotype and phenotype in susceptibility to coal workers' pneumoconiosis. The use of cytokines in perspective. Eur. Respir. J. 32:127S-33S
89. Bignon JS, Aron Y, Ju LY, et al. 1994. HLA class II alleles in isocyanate-induced asthma. Am. J. Respir. Crit. Care Med. 149:71-75
90. Mapp CE, Fryer AA, DeMarzo N, et al. 2002. Glutathione S-transferase GSTP1 is a susceptibility gene for occupational asthma induced by isocyanates. J. Allergy Clin. Immunol. 109:867-72
91. Grandjean P, ed. 1991. Ecogenetics. Genetic Predisposition to the Toxic Effects of Chemicals. London: Chapman & Hall
92. Bascom R, Bromberg PA, Costa DA, et al. 1996. Health effects of outdoor air pollution. Am. J. Respir. Crit. Care Med. 153:3-50
93. Jakab GJ, Spannhake EW, Canning BJ, et al. 1995. The effects of ozone on immune function. Environ. Health Perspect. 103(Suppl. 2):77-89
94. Weinmann GG, Bowes SM, Gerbase MW, et al. 1995. Response to acute ozone exposure in healthy men. Results of a screening procedure. Am. J. Respir. Crit. Care Med. 151:33-40
95. Aris RM, Christian D, Hearne PQ, et al. 1993. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am. Rev. Respir. Dis. 148:1363-72
96. Bergamaschi E, De Palma G, Mozzoni P, et al. 2001. Polymorphism of quinone-metabolizing enzymes and susceptibility to ozone-induced acute effects. Am. J. Respir. Crit. Care Med. 163:1426-31
97. Kleeberger SR, Levitt RC, Zhang LY, et al. 1997. Linkage analysis of susceptibility to ozone-induced lung inflammation in inbred mice. Nat. Genet. 17:475-78
98. Kleeberger SR, Reddy S, Zhang LY, et al. 2000. Genetic susceptibility to ozone-induced lung hyperpermeability. Role of toll-like receptor 4. Am. J. Respir. Cell Mol. Biol. 22:620-27
99. Pope CA III, Thun MJ, Namboodiri MM, et al. 1995. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am. J. Respir. Crit. Care Med. 151:669-74
100. Raizenne M, Neas LM, Damokosh AI, et al. 1996. Health effects of acid aerosols on North American children: pulmonary function. Environ. Health Perspect. 104:506-14
101. Schwartz J. 1994. What are people dying of on high air pollution days? Environ. Res. 64:26-35
102. Ohtsuka Y, Brunson KJ, Jedlicka AE, et al. 2000. Genetic linkage analysis of susceptibility to particle exposure in mice. Am. J. Respir. Cell Mol. Biol. 22:574-81
103. Moss M, Bucher B, Moore FA, et al. 1996. The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA 275:50-54
104. Moss M, Guidot DM, Steinberg KP, et al. 2000. Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit. Care Med. 28:2187-92
105. Gong MN, Wei Z, Xu L-L, et al. 2004. Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. Chest 125:203-11
106. Marshall R, Webb S, Bellingan GJ, et al. 2002. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 166:646-50
107. Cho H, Jedlicka A, Reddy SPM, et al. 2002. Linkage analysis of susceptibility to hyperoxia: Nrf2 is a candidate gene. Am. J. Respir. Cell Mol. Biol. 26:42-51
108. Cho H, Jedlicka A, Reddy SPM, et al. 2002. Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol. 26:175-58
109. Cho H, Reddy SPM, Yamamoto M, et al. 2004. The transcription factor NRF2 protects against pulmonary fibrosis. FASEB J. 18:1258-60